StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

PLX — Protalix BioTherapeutics, Inc.

FAIR (MOS +3.2%) · Quality 87/100

Price
2.69
Intrinsic value
2.78
Margin of safety
+3.2%
Implied growth (reverse DCF)
+19.6%
model assumes +20.0%
Value Score
34.8
Quality
87
Psychology
-17.3
Discovery
19.3
price/volume attention only
Moat score
26.2
erosion: none

Value Score: top 46% of Russell 3000 · Quality: top 2%

Open the interactive Deep Dive for PLX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/PLX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is PLX undervalued?

As of 2026-09-19, PLX trades at 2.69 against a computed intrinsic value of 2.78 (+3.2% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is Protalix BioTherapeutics, Inc.'s Value Score?

Protalix BioTherapeutics, Inc.'s Value Score is 34.8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.